News
CEO Raises Cancer Drug Price Tag 5,000% Because Drug Was ‘Unprofitable’
In August, Turing Pharmaceutical bought the 62-year-old patent on a drug called Daraprim. Almost overnight, the company raised the price of the drug from $13.50 to $750. The medical community ...
Read more ›